HMS’s (HMSY) “Outperform” Rating Reaffirmed at William Blair

William Blair reiterated their outperform rating on shares of HMS (NASDAQ:HMSY) in a report issued on Thursday.

Other analysts have also recently issued reports about the stock. Zacks Investment Research cut shares of HMS from a buy rating to a hold rating in a report on Thursday, February 21st. BidaskClub cut shares of HMS from a buy rating to a hold rating in a research note on Wednesday, January 16th. Finally, Cantor Fitzgerald reaffirmed a hold rating and set a $34.00 target price on shares of HMS in a research note on Friday, February 22nd. Five research analysts have rated the stock with a hold rating and eight have given a buy rating to the company. The stock has an average rating of Buy and an average price target of $33.50.

Shares of NASDAQ:HMSY traded up $0.14 during mid-day trading on Thursday, hitting $32.20. 5,760 shares of the company traded hands, compared to its average volume of 660,222. The company has a market cap of $2.74 billion, a P/E ratio of 38.44, a PEG ratio of 3.02 and a beta of 1.64. The company has a debt-to-equity ratio of 0.34, a quick ratio of 4.40 and a current ratio of 4.40. HMS has a 52-week low of $16.29 and a 52-week high of $38.15.

HMS (NASDAQ:HMSY) last announced its earnings results on Friday, February 22nd. The business services provider reported $0.28 EPS for the quarter, beating the consensus estimate of $0.25 by $0.03. HMS had a return on equity of 14.21% and a net margin of 9.19%. The business had revenue of $155.80 million for the quarter, compared to the consensus estimate of $155.84 million. During the same period last year, the business posted $0.24 EPS. The company’s revenue was up 4.9% on a year-over-year basis. Analysts predict that HMS will post 0.97 earnings per share for the current year.

In other HMS news, Chairman William C. Lucia sold 182,702 shares of the stock in a transaction on Wednesday, February 27th. The stock was sold at an average price of $34.55, for a total value of $6,312,354.10. Following the transaction, the chairman now directly owns 230,015 shares in the company, valued at approximately $7,947,018.25. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Teresa South sold 216,903 shares of the stock in a transaction on Thursday, February 28th. The shares were sold at an average price of $34.57, for a total value of $7,498,336.71. Following the completion of the transaction, the insider now owns 137,622 shares in the company, valued at $4,757,592.54. The disclosure for this sale can be found here. Insiders have sold a total of 971,526 shares of company stock valued at $33,510,192 over the last ninety days. Insiders own 4.54% of the company’s stock.

A number of institutional investors and hedge funds have recently made changes to their positions in the business. We Are One Seven LLC acquired a new position in HMS during the fourth quarter valued at approximately $84,000. BlueMountain Capital Management LLC bought a new stake in shares of HMS in the 3rd quarter valued at about $146,000. LS Investment Advisors LLC boosted its stake in HMS by 80.0% in the 4th quarter. LS Investment Advisors LLC now owns 5,016 shares of the business services provider’s stock worth $141,000 after purchasing an additional 2,230 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank boosted its stake in HMS by 11.3% in the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 5,826 shares of the business services provider’s stock worth $164,000 after purchasing an additional 592 shares in the last quarter. Finally, Ibex Investors LLC acquired a new stake in HMS in the 3rd quarter worth approximately $210,000. Hedge funds and other institutional investors own 95.19% of the company’s stock.

HMS Company Profile

HMS Holdings Corp., through its subsidiaries, provides cost containment solutions in the United States healthcare marketplace. It provides coordination of benefits services to government and commercial healthcare payers and sponsors to coordinate benefits for claims; and payment integrity services that ensure healthcare claims billed are accurate and appropriate, as well as offers care management and consumer engagement solutions.

Read More: Cash Flow

Analyst Recommendations for HMS (NASDAQ:HMSY)

Receive News & Ratings for HMS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HMS and related companies with MarketBeat.com's FREE daily email newsletter.